Thrombocytopenia in Paediatric ICU: Incidence, Transfusion Requirement and Role as Prognostic Indicator

Amarpreet Kaur1, Gurmeet Kaur Sethi2, Ram Kumar Goyal3

  • 1Assistant Professor, Department of Pediatrics, Guru Gobind Singh Medical College and Hospital , Faridkot, Punjab, India .

Insights

Thrombocytopenia, a low platelet count, is common in pediatric intensive care units (PICUs) and significantly increases mortality risk, especially when associated with sepsis.

Area of Science:

  • Pediatric critical care medicine
  • Hematology
  • Infectious diseases

Background:

  • Thrombocytopenia (platelet count < 150×10^9/L) is more frequent in Intensive Care Units (ICUs) than general wards.
  • Increased platelet consumption is the primary cause of thrombocytopenia in critically ill patients.

Purpose of the Study:

  • Investigate the incidence of thrombocytopenia in a pediatric ICU (PICU).
  • Determine the requirement for platelet transfusions.
  • Analyze associated diseases and the relationship between thrombocytopenia and mortality.

Main Methods:

  • Retrospective analysis of 275 critically ill children's hospital records over 11 months.
  • Statistical analysis using Odds Ratio, 95% confidence intervals, and Chi-squared test.
  • A p-value < 0.05 was considered statistically significant.

Main Results:

  • Out of 275 patients, 89 (32.36%) had thrombocytopenia, with 43 (48.31%) experiencing severe cases.
  • Sepsis (25.84%) was the most frequent diagnosis among thrombocytopenic patients.
  • A significant association was found between thrombocytopenia and increased mortality, particularly in sepsis patients.

Conclusions:

  • Thrombocytopenia is a common complication in critically ill children, frequently linked to sepsis.
  • The presence of thrombocytopenia is associated with a higher mortality rate in the pediatric intensive care setting.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
472
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
645
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
460
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
370
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
460